Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin for Prostate Cancer Detection (PREP Trial)
NCT02252978Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jul 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciprofloxacin in prostate cancer (PCa), sponsored by Wake Forest University Health Sciences. Planned start Jul 2016; status: withdrawn.
02
Drugs
ciprofloxacin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02252978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252978.